| IMRX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||
Below is a table of the IMRX shares outstanding history going back to 9/3/2021:
Also see: IMRX Market Cap History IMRX YTD Return |
IMRX Shares Outstanding History — Immuneering Share Count Over Time
As of 5/11/2026 Immuneering has 64.70 million IMRX shares outstanding. Investors often track the IMRX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows IMRX share count trends over time, with 19 historical shares outstanding datapoints presented, dating back to 9/3/2021.
| IMRX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||
IMRX Historical Shares Outstanding: +21.53% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||
| IMRX Stock Price Chart |
| About Immuneering Corp |
| Immuneering Corporation is a clinical-stage oncology company. Co. is engaged in the development of medicines for cancer patients with universal-RAS therapy. Co.'s lead product candidate, IMM-1-104, in under Phase I/IIa clinical trial in patients with advanced solid tumors harboring RAS mutations. IMM-1-104 is being developed as a once-daily oral monotherapy that aims to achieve universal-RAS activity through deep cyclic inhibition of the MAPK pathway. Co.'s second product candidate, IMM-6-415, aims to achieve universal-MAPK activity with an accelerated twice-daily oral dosing cadence, also through deep cyclic inhibition of the MAPK pathway. We show 19 historical shares outstanding datapoints in our coverage of IMRX's shares outstanding history. Understanding the changing numbers of IMRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like IMRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching IMRX by allowing them to research IMRX shares outstanding history as well as any other stock in our coverage universe. |
| IMRX Current Stock Quote |
Quotes delayed 20 minutes  Free IMRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| IMRX Share Performance |
| Shares Outstanding Peers |
| Immuneering (IMRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
IMUX Shares Outstanding History IMV Shares Outstanding History IMVT Shares Outstanding History INAB Shares Outstanding History INBS Shares Outstanding History INBX Shares Outstanding History INCY Shares Outstanding History INDP Shares Outstanding History INDV Shares Outstanding History INFI Shares Outstanding History More Healthcare companies » |
IMRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
